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Understanding the factors that inﬂuence human health and
cause diseases has always been one of the majordriving forces
of biological research. With the spectacular progresses in
quantitative techniques, large-scale measurement methods
and with the intimate integration between experimental and
computational approaches, Biology has recently acquired new
technological and conceptual tools to investigate, model and
understand livingorganisms atthesystem level.While thestill
young discipline of Systems Biology has been most widely
devoted to the study of well-characterized model organisms, it
has been clear since the early days of the human genome
project that applications of system-wide approaches to human
biology would open up tremendous opportunities in medicine.
Recent lessons learned from Systems Biology, when applied
tosimpleorganismslikebacteriaoryeast,preﬁgurethekindof
insights that will beneﬁt both basic medical research and
clinical applications: deeper understanding of the genotype–
phenotype relationship; impact of the interactions between
environmental conditions and genotype; novel mechanistic
and functional insights based on global unbiased approaches;
elaboration of powerful predictive models capturing the
intricacies of physiological states. Advances on these various
frontsobviouslydependondifferenttypesofresearch,ranging
from investigations on fundamental aspects of human biology
to the more clinically oriented applications. Signiﬁcantly, as
techniques and concepts mature, a new discipline is emerging
at the interface between Medicine and Systems Biology. To
provide a snapshot of this evolving ﬁeld of Systems Medicine
and to illustrate new insights gained by applying Systems
Biology approaches within the context of human health and
disease, Molecular Systems Biology releases this month, in
print, a collection of articles recently published in the journal.
In many ﬁelds relevant to medical research, including
cancer biology, deciphering the mechanisms of disease
requires a deep knowledge of how signaling transduction
pathways operate. Quantitative proteomics has made possible
the simultaneous monitoring of the concurrent activity of
multiplesignalingmolecules,enablingabroaderandunbiased
view of cellular signaling events. The work by White and co-
workers (Wolf-Yadlin et al, 2006) illustrates how this type of
high-throughput data can be correlated to biological response
(e.g., proliferation and cell migration) to further our under-
standing of one of the major pathways known to be
deregulated in cancer. These global approaches also reveal
the inescapable fact that biological pathways are highly
interconnected,whichrepresentsoneofthemajormotivations
for adopting a system-level approach in biology. In the study
by Leha ´r et al (2007), the impact of connectivity on biological
outcome is analyzed to explain synergies and other non-
intuitive interactions observed between simultaneously ap-
plied drugs, with important consequences for drug design and
pharmacology. In fact, the classical concept of linear pathways
is being increasingly challenged by network representations,
which emphasize the importance of interactions between
components of a biological system. Loscalzo et al (2007)
discuss how this network-based conceptual framework may
transform current paradigms in disease classiﬁcation and
treatment. However, a major practical challenge is how to
deduce the structure of complex networks that underlie
biological processes and how to characterize their state when
perturbed bydisease. Newcomputational strategies combined
with the now well-established genome-wide expression
proﬁling techniques provide completely new tools to reverse-
engineernetworkstructureandtoidentifyandtrackmediators
associated with a disease as illustrated by the work of Jim
Collins’ team on prostate cancer (Ergu ¨n et al, 2007).
Since the completion of the human genome sequence,
research in human genetics has been progressing at a rapid
pace. With major achievements including realization of the
HapMap project facilitating the analysis of human genetic
variability, the recent ﬂurry of genome-wide associated
studies providing a host of potential genetic determinants for
major common diseases and the advent of the ﬁrst persona-
lized human genome sequences, the power of genetics
and genomics to explore the human disease landscape does
not need to be demonstrated any more. But it is important
to realize that beyond genetic determinants, diseases are
characterized by a perturbed physiology, and methods
providing a wider and deeper window into physiological
states will be instrumental to acquire an integrated view of
human disease. By their proximity to physiological output,
metabolite measurements provide such a window, and
advances in the associated techniques have led to the
development of the ﬁeld of metabonomics, pioneered by
Jeremy Nicholson. His study (Martin et al, 2007) reveals
the profound inﬂuence exerted by gut bacterial ﬂora on
the metabolic equilibrium of the host and, as a consequence,
on its health status. This work also demonstrates that the
genotype–phenotype relationship is far from being the entire
story when dealing with disease, and it highlights the crucial
importance of integrating all facets of physiology, including
contributions from the microbiome and environment, thus
adopting an even wider scope than the genome-wide
paradigm.
One of the great hopes generated by the application of high-
throughput technologies to human samples is that the
increased amount of information gathered can lead to more
powerful models able to predict susceptibility to disease,
response to treatment and, perhaps even more challenging,
help in the prognosis of disease outcome. It is the latter
question of prognosis that is addressed in the study by
MacBeath and co-workers (Knickerbocker et al, 2007), where
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measurements of blood samples allows improved prediction
of early mortality of patients initiating a kidney dialysis
treatment. Wider application of these technologies is likely to
be instrumental in opening the door to the era of personalized
medicinewithtailoredstrategiesencompassingalldimensions
of clinical practice, including prevention, diagnosis, treatment
and prognosis.
Translating the Systems Biology framework to the human
‘system’ will represent a formidable challenge, not only
because of the daunting complexity of human physiology,
but also because the human condition implies serious
consideration of ethical, legal, safety, individual and
epidemiological issues. Revolutionary technologies, novel
insights, massive digitalization of information will call
for clear thinking and innovation in the formulation
of governance policies. It is thus also our hope that by
providing an excerpt of some of the recent concrete contribu-
tion to the ﬁeld, we can stimulate, already at this early
stage, reﬂections and debates, extending beyond the Systems
Biology community, so that the full potential and promises of
Systems Medicine can be realized in harmony with societal
standards.
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